Company Profile

KINTOR PHARMA-B

9939 Biotechnology
Description

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in researching, developing, and commercializing therapeutic drugs for dermatology and tumors indications with the unmet medical needs in the People's Republic of China. Its product candidates include KX-826, a potential topical drug for the treatment of androgenic alopecia and acne vulgaris; and Pruxelutamide (GT0918), a second-generation androgen receptor (AR) for the treatment of metastatic castration-resistant prostate cancer, COVID-19, and AR+ metastatic breast cancer, as well as AR-PROTAC Compound (GT20029). The company is developing Pruxelutamide (GT0918), a second generation androgen receptor (AR) for the metastatic castration-resistant prostate cancer, COVID-19, and AR+ metastatic breast cancer; GT1708F (Hedgehog/SMO Inhibitor), an inhibitor of the hedgehog signal transduction pathway to treat idiopathic pulmonary fibrosis, and blood cancer; GT0486, an inhibitor of the PI3K/mTOR signalling pathway and a second generation mTOR inhibitor for the treatment of metastatic solid tumours, such as breast cancer, prostate cancer, and hepatocellular carcinoma (HCC); and ALK-1 Antibody (GT90001), an anti-angiogenesis inhibitor and targets a new biological target activin receptor-like kinase-1 globally to treat metastatic hepatocellular carcinoma, a common type of liver cancer, and a variety of solid tumours. Kintor Pharmaceutical Limited was founded in 2009 and is headquartered in Suzhou, the People's Republic of China.

Reports

This company has 5 ESG reports available.

ESG Performance Overview

Select a KPI indicator to view performance trend

KPI Indicators

A1.1 Emission Types and Data
24 Data Points
Indicator Data Points Actions
SOₓ Emissions 8
NOₓ Emissions 8
Airborne Particulate Matter (PM) Emissions 8
A1.2 Direct (Scope 1) and Indirect (Scope 2) GHG Emissions
32 Data Points
Indicator Data Points Actions
Total GHG Emissions Intensity (By Employee) 8
Total GHG Emissions 8
Direct GHG Emissions (Scope 1) 8
Indirect Energy Emissions (Scope 2) 8
A1.3 Hazardous Waste
16 Data Points
Indicator Data Points Actions
Total Hazardous Waste Intensity (By Employee) 8
Total Hazardous Waste 8
A1.4 Non-Hazardous Waste
16 Data Points
Indicator Data Points Actions
Non-Hazardous Waste Disposed 8
Total Non-Hazardous Waste Intensity (By Employee) 8
A1.5 Emission Targets
3 Data Points
Indicator Data Points Actions
Target GHG Emissions Reduction Percentage Compared to Last Year 3

A2.1 Energy Consumption
42 Data Points
Indicator Data Points Actions
Energy Consumption Intensity (By Employee) 8
Total Energy Consumption 8
Gasoline Consumption 8
Natural Gas Consumption 8
Total Indirect Energy Consumption 2
Purchased Electricity 8
A2.2 Water Consumption
8 Data Points
Indicator Data Points Actions
Water Consumption 8
A2.5 Total Packaging Material Used
16 Data Points
Indicator Data Points Actions
Packaging Materials Consumed 8
Packaging Material Intensity (By Unit Product) 8

B1.1 Amount and Distribution of Workforce
99 Data Points
Indicator Data Points Actions
Number of Total Employees 5
Number of Male Employees 5
Number of Female Employees 5
Percentage of Male Employees 5
Percentage of Female Employees 5
Number of Full-time Employees 5
Number of Part-time Employees 5
Number of Temporary Workers 5
Percentage of Full-time Employees 5
Percentage of Part-time Employees 5
Percentage of Temporary Workers 5
Number of Employees Aged Below 30 5
Number of Employees Aged 30-50 5
Number of Employees Aged Above 50 5
Percentage of Employees Aged Below 30 5
Percentage of Employees Aged 30-50 5
Percentage of Employees Aged Above 50 5
Number of Employees in Hong Kong 5
Number of Employees in United States 5
Percentage of Employees in Hong Kong 2
Percentage of Employees in United States 2
B1.2 Employee Turnover Rate
46 Data Points
Indicator Data Points Actions
Turnover Rate of Female Employees 5
Turnover Rate of Full-time Employees 2
Turnover Rate of Male Employees 5
Turnover Rate of Part-time Employees 2
Turnover Rate of Temporary Workers 2
Turnover Rate of Employees Aged Below 30 5
Turnover Rate of Employees Aged 30-50 5
Turnover Rate of Employees Aged Above 50 5
Turnover Rate of Employees in Hong Kong 5
Turnover Rate of Total Employees 5
Turnover Rate of Employees in United States 5

B2.1 Number and Rate of Work-related Fatalities
1 Data Points
Indicator Data Points Actions
Number of Fatalities of the Last 3 Years 1
B2.2 Lost Days Due to Work Injury
1 Data Points
Indicator Data Points Actions
Lost Days Due to Work-related Injuries 1

B3.1 The Percentage of Employees Trained
12 Data Points
Indicator Data Points Actions
Percentage of Employees Trained 2
Percentage of Trained Male Employees 2
Percentage of Trained Female Employees 2
Percentage of Trained Senior Management 2
Percentage of Trained Middle Management 2
Percentage of Trained General Employees 2
B3.2 Average Training Hours Completed per Employee
12 Data Points
Indicator Data Points Actions
Average Training Hours per Employee 2
Average Training Hours (Male) 2
Average Training Hours (Female) 2
Average Training Hours (Senior Management) 2
Average Training Hours (Middle Management) 2
Average Training Hours (General Staff) 2

B4.1 Avoid Child and Forced Labour
1 Data Points
Indicator Data Points Actions
Number of Violation Cases Related to Child Labour or Forced Labour 1

B5.1 Number of Suppliers by Geographical Region
4 Data Points
Indicator Data Points Actions
Number of Total Suppliers 2
Number of Suppliers in Mainland China 2